Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

03/01/2020 AllRead MLT, a success story originated from the PRUAB’s Ideas Generation Program 06/11/2019 SENER, a top-class aerospace systems provider 29/10/2019 The ICN2 research center is involved in the quantum revolution 21/10/2019 Stradivarius keeps growing 19/09/2019 The president of Catalonia visited the Barcelona Synchrotron Park 12/09/2019 Alba, a tool to tackle challenges in the fields of renewable energy production and fight against air pollution
2 3 4 5 6 7 8 9 10 11 12